Nexi


Tempered by COVID-19, precarity and the Nordics

31/03/21 -"Our new target price reflects our pessimism regarding the COVID-19 situation in Italy. It is also fed by doubts over the growth potential in the Nordics. We keep a positive opinion given the current ..."

Pages
47
Language
English
Published on
31/03/21
You may also be interested by these reports :
12/04/21
It is a bad habit of the English-speaking financial press to derail German financial firms for being late in the game and prone to colossal mistakes. ...

12/04/21
We have updated our earnings estimates after incorportating the FY20 results and rolling forward our estimates through 2023. Our FY20 EPS estimates ...

09/04/21
HAL’s NAV performance through 2020 fell victim to the touchy discussions between EssilorLuxottica and GrandVision as the terms of the acquisition ...

08/04/21
We are (slightly) revising upwards our EPS for 2022 on the back of the integration of Lyxor at the beginning of 2022.

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO